4//SEC Filing
Nusse Roeland 4
Accession 0001062993-23-009442
CIK 0000842023other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:02 PM ET
Size
17.1 KB
Accession
0001062993-23-009442
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Nusse Roeland
Director
Transactions
- Gift
Common Stock
2023-04-19−377→ 28,811 total
Holdings
- 15,940
Stock Options (Right to Buy)
Exercise: $25.30From: 2017-10-26Exp: 2026-10-27→ Common Stock (15,940 underlying) - 3,460
Stock Options (Right to Buy)
Exercise: $73.94Exp: 2032-10-27→ Common Stock (3,460 underlying) - 16,000
Stock Options (Right to Buy)
Exercise: $21.85From: 2013-10-31Exp: 2023-10-30→ Common Stock (16,000 underlying) - 17,040
Stock Options (Right to Buy)
Exercise: $21.84From: 2016-10-29Exp: 2025-10-28→ Common Stock (17,040 underlying) - 7,592
Stock Options (Right to Buy)
Exercise: $44.96From: 2019-10-24Exp: 2028-10-25→ Commo Stock (7,592 underlying) - 2,532
Stock Options (Right to Buy)
Exercise: $128.81From: 2022-10-27Exp: 2031-10-28→ Common Stock (2,532 underlying) - 16,000
Stock Options (Right to Buy)
Exercise: $22.95From: 2014-10-30Exp: 2024-10-30→ Common Stock (16,000 underlying) - 12,500
Stock Options (Right to Buy)
Exercise: $31.26From: 2018-10-25Exp: 2027-10-26→ Common Stock (12,500 underlying) - 8,044
Stock Options (Right to Buy)
Exercise: $50.41From: 2020-10-24Exp: 2029-10-24→ Common Stock (8,044 underlying) - 6,028
Stock Options (Right to Buy)
Exercise: $63.92From: 2021-10-28Exp: 2030-10-29→ Common Stock (6,028 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001492695
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 4:02 PM ET
- Size
- 17.1 KB